AI assistant
Sending…
AIM ImmunoTech Inc. — Director's Dealing 2015
Apr 29, 2015
35334_dirs_2015-04-29_df46a063-0443-4717-8caf-5ddb9ca04a7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2015-04-28
Reporting Person: CARTER WILLIAM A (Director, CEO, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-28 | Common Stock | P | 100000 | $0.242 | Acquired | 1150585 | Direct |